Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (1130)	2/10/1999 4:21:00 AM
From: SteveR	Read Replies (1) \| Respond to of 2539

02/10 03:33 Monsanto's Celebrex is No. 2 in prescriptions -WSJ NEW YORK, Feb 10 (Reuters) - Monsanto Co.'s <MTC.N> arthritis pain drug Celebrex generated prescriptions in its third week on the market at more than six times those of cholesterol drug Lipitor at a comparable stage, the Wall Street Journal said on Wednesday. Celebrex produced 82,000 prescriptions in the week ended Sunday, making it the second-fastest start for a new drug in recent years, surpassing Lipitor, which had 13,100 prescriptions written in its third week in 1997, according to a report by pharmaceutical information provider NDC Health Information Services, the paper said. Lipitor, which is co-marketed by Warner-Lambert Co. <WLA.N> and Pfizer Inc. <PFE.N>, is expected to generate $3.1 billion in sales this year, the paper said. Celebrex's sales are exceeded only by those of Pfizer impotence drug Viagra, which sold 224,100 prescriptions in its third week, the paper said. Pfizer is also co-marketing Celebrex with Monsanto. Monsanto shares fell 11/16 to 45-1/8 and Pfizer shares fell 6-1/8, to 125-1/4 in New York Stock Exchange trade Tuesday, a day the Dow Jones Industrials lost 1.70 percent falling 158.08 to 9133.03. ((--New York Newsdesk (212) 859-1700)) COPYRIGHT © 1998 REUTERS LIMITED. ALL RIGHTS RESERVED.

To: Dan Spillane who wrote (1130)	2/10/1999 7:34:00 PM
From: Anthony Wong	Respond to of 2539

02/10 18:51 EPA Grants Approval to Increase Monsanto's YieldGard Corn Acres in South EPA Grants Approval to Increase Monsanto's YieldGard Corn Acres in South ST. LOUIS, Feb. 10 /PRNewswire/ -- Corn growers, who had been severely restricted in the amount of YieldGard (MON-810) insect-protected corn they could plant in cotton-producing regions of the South, are now able to plant up to 50 percent of their acres with these improved hybrids that protect the corn plant against European corn borer, Southwestern corn borer, and other insects. Monsanto Co. received approval from the U.S. Environmental Protection Agency to increase the amount of YieldGard insect-protected corn that can be grown in cotton producing regions of the South. "We are pleased that the EPA was responsive to our petition and the data we submitted," said Eric Sachs, YieldGard business director for Monsanto. "Growers in the South have told us they have been extremely frustrated that they have not been given full access to this environmentally responsible technology that will allow them to increase their corn yields. We will continue working to get them more access in 1999." Sachs said he is optimistic that the EPA will continue to review data submitted by Monsanto and further lift restrictions in the northern corn-cotton growing regions so that growers can benefit more fully from YieldGard's protection. The EPA had significant input from grower organizations, as well as congressional delegates during their consideration of lifting the limitations on this valuable technology. Also, Monsanto will continue to participate fully in the Insect Resistance Management coalition which consists of Bt corn registrants. This effort is being promoted by the National Corn Growers Association in an effort to introduce an industry wide refuge plan for the year 2000. YieldGard and other insect-protected corn brands had been restricted in the South because of concern that a species of insect could develop resistance to the protective gene in the corn. The corn contains a gene from Bacillus thuringiensis (Bt), which protects corn from specific pests, including corn earworm and Fall armyworm. The corn earworm is the same species as the cotton bollworm, a major pest of cotton. In a typical year of corn borer pressure, YieldGard hybrids produce about 7 percent more corn per acre than ordinary corn. As a life sciences company, Monsanto is committed to finding solutions to the growing global needs for food and health by sharing common forms of science and technology among agriculture, nutrition and health. The company's 30,000 employees worldwide make and market high-value agricultural products, pharmaceuticals and food ingredients. YieldGarde(R) is a registered trademark of Monsanto Company. SOURCE Monsanto Company -0- 02/10/99 /CONTACT: Randy Krotz of Monsanto Company, 314-694-6193, or e-mail, randy.p.krotz@monsanto.com/ /Web site: monsanto.com -- CGW080 -- 2618 02/10/99 18:36 EST prnewswire.com Copyright PR Newswire 1998. All rights reserved.